Heparin detection by the activated coagulation time: A comparison of the sensitivity of coagulation tests and heparin assays

David J. Murray, William J. Brosnahan, Beverly Pennell, David Kapalanski, John M. Weiler, John D Olson

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Objective: Laboratory and point-of-care coagulation tests are frequently obtained to determine the presence of heparin after surgical procedures. The objective of this study was (1) to compare the sensitivity of the activated coagulation time (ACT), activated partial thromboplastin time (aPTT), protamine titration (Hepcon; HMS Medtronic, Hemotec, Englewood, CO), and thromboelastography (TEG) with heparin anticoagulation and (2) to determine how frequently residual heparin is present in the 24-hour period after heparin neutralization in cardiopulmonary bypass (CPB) patients. Design: A prospective study. Setting: A tertiary care university teaching center that performs more than 15,000 surgical procedures per year. Participants: Vascular surgical (n = 17) and CPB (n = 29). Interventions: In vascular surgical patients, coagulation tests (ACT, protamine titration [Hepcon], and TEG) were obtained before and 90 minutes after heparin (50 to 60 U/kg IV) and compared with heparin concentration determined by factor Xa inhibition assay. In cardiac surgical patients, ACT and heparin concentrations were measured after anesthesia induction, during CPB, after protamine neutralization, and 3 as well as 6 hours after CPB. In addition to heparin concentrations and ACT measures, platelet counts, fibrinogen levels, and bleeding times were determined before and 3 and 24 hours after CPB. Measurements and Main Results: Ninety minutes after heparin, significant heparin concentrations were present in all vascular surgical patients, but ACT was elevated in only 4 of 17 patients. Protamine titration (Hepcon) correlated with the factor Xa inhibitory assay for heparin (r2 = 0,76). All 17 patients had an abnormal TEG (mean 'R' time = 81 ± 39 minutes) and a marked elevation of aPTT (135 ± 35 sec [normal 22 to 33 seconds]) 90 minutes after heparin. In CPB patients, ACT did not correlate with heparin assays. After protamine neutralization of heparin in CPB patients, ACT returned to baseline despite the presence of heparin in 3 of 29 patients (0.22, 0.18, and 0.33 U/mL). Conclusions: ACT was less sensitive to residual heparin anticoagulation than aPTT, TEG, and whole blood heparin assay. The whole blood heparin assay (Hapcon) provided sensitive and specific data about the presence of residual heparin. Despite the limitation of ACT in detecting heparin, the investigators found that residual heparin was not common in the period after uncomplicated CPB.

Original languageEnglish (US)
Pages (from-to)24-28
Number of pages5
JournalJournal of Cardiothoracic and Vascular Anesthesia
Volume11
Issue number1
DOIs
StatePublished - Feb 1997
Externally publishedYes

Fingerprint

Heparin
Cardiopulmonary Bypass
Protamines
Thrombelastography
Partial Thromboplastin Time
Blood Vessels
Factor Xa
Point-of-Care Systems
Bleeding Time
Tertiary Healthcare
Carbon Monoxide
Platelet Count
Fibrinogen

Keywords

  • activated coagulation time
  • cardiopulmonary bypass
  • coagulation tests
  • heparin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Heparin detection by the activated coagulation time : A comparison of the sensitivity of coagulation tests and heparin assays. / Murray, David J.; Brosnahan, William J.; Pennell, Beverly; Kapalanski, David; Weiler, John M.; Olson, John D.

In: Journal of Cardiothoracic and Vascular Anesthesia, Vol. 11, No. 1, 02.1997, p. 24-28.

Research output: Contribution to journalArticle

Murray, David J. ; Brosnahan, William J. ; Pennell, Beverly ; Kapalanski, David ; Weiler, John M. ; Olson, John D. / Heparin detection by the activated coagulation time : A comparison of the sensitivity of coagulation tests and heparin assays. In: Journal of Cardiothoracic and Vascular Anesthesia. 1997 ; Vol. 11, No. 1. pp. 24-28.
@article{42b0f99be6d144a3bb2f4a745a522423,
title = "Heparin detection by the activated coagulation time: A comparison of the sensitivity of coagulation tests and heparin assays",
abstract = "Objective: Laboratory and point-of-care coagulation tests are frequently obtained to determine the presence of heparin after surgical procedures. The objective of this study was (1) to compare the sensitivity of the activated coagulation time (ACT), activated partial thromboplastin time (aPTT), protamine titration (Hepcon; HMS Medtronic, Hemotec, Englewood, CO), and thromboelastography (TEG) with heparin anticoagulation and (2) to determine how frequently residual heparin is present in the 24-hour period after heparin neutralization in cardiopulmonary bypass (CPB) patients. Design: A prospective study. Setting: A tertiary care university teaching center that performs more than 15,000 surgical procedures per year. Participants: Vascular surgical (n = 17) and CPB (n = 29). Interventions: In vascular surgical patients, coagulation tests (ACT, protamine titration [Hepcon], and TEG) were obtained before and 90 minutes after heparin (50 to 60 U/kg IV) and compared with heparin concentration determined by factor Xa inhibition assay. In cardiac surgical patients, ACT and heparin concentrations were measured after anesthesia induction, during CPB, after protamine neutralization, and 3 as well as 6 hours after CPB. In addition to heparin concentrations and ACT measures, platelet counts, fibrinogen levels, and bleeding times were determined before and 3 and 24 hours after CPB. Measurements and Main Results: Ninety minutes after heparin, significant heparin concentrations were present in all vascular surgical patients, but ACT was elevated in only 4 of 17 patients. Protamine titration (Hepcon) correlated with the factor Xa inhibitory assay for heparin (r2 = 0,76). All 17 patients had an abnormal TEG (mean 'R' time = 81 ± 39 minutes) and a marked elevation of aPTT (135 ± 35 sec [normal 22 to 33 seconds]) 90 minutes after heparin. In CPB patients, ACT did not correlate with heparin assays. After protamine neutralization of heparin in CPB patients, ACT returned to baseline despite the presence of heparin in 3 of 29 patients (0.22, 0.18, and 0.33 U/mL). Conclusions: ACT was less sensitive to residual heparin anticoagulation than aPTT, TEG, and whole blood heparin assay. The whole blood heparin assay (Hapcon) provided sensitive and specific data about the presence of residual heparin. Despite the limitation of ACT in detecting heparin, the investigators found that residual heparin was not common in the period after uncomplicated CPB.",
keywords = "activated coagulation time, cardiopulmonary bypass, coagulation tests, heparin",
author = "Murray, {David J.} and Brosnahan, {William J.} and Beverly Pennell and David Kapalanski and Weiler, {John M.} and Olson, {John D}",
year = "1997",
month = "2",
doi = "10.1016/S1053-0770(97)90247-0",
language = "English (US)",
volume = "11",
pages = "24--28",
journal = "Journal of Cardiothoracic and Vascular Anesthesia",
issn = "1053-0770",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Heparin detection by the activated coagulation time

T2 - A comparison of the sensitivity of coagulation tests and heparin assays

AU - Murray, David J.

AU - Brosnahan, William J.

AU - Pennell, Beverly

AU - Kapalanski, David

AU - Weiler, John M.

AU - Olson, John D

PY - 1997/2

Y1 - 1997/2

N2 - Objective: Laboratory and point-of-care coagulation tests are frequently obtained to determine the presence of heparin after surgical procedures. The objective of this study was (1) to compare the sensitivity of the activated coagulation time (ACT), activated partial thromboplastin time (aPTT), protamine titration (Hepcon; HMS Medtronic, Hemotec, Englewood, CO), and thromboelastography (TEG) with heparin anticoagulation and (2) to determine how frequently residual heparin is present in the 24-hour period after heparin neutralization in cardiopulmonary bypass (CPB) patients. Design: A prospective study. Setting: A tertiary care university teaching center that performs more than 15,000 surgical procedures per year. Participants: Vascular surgical (n = 17) and CPB (n = 29). Interventions: In vascular surgical patients, coagulation tests (ACT, protamine titration [Hepcon], and TEG) were obtained before and 90 minutes after heparin (50 to 60 U/kg IV) and compared with heparin concentration determined by factor Xa inhibition assay. In cardiac surgical patients, ACT and heparin concentrations were measured after anesthesia induction, during CPB, after protamine neutralization, and 3 as well as 6 hours after CPB. In addition to heparin concentrations and ACT measures, platelet counts, fibrinogen levels, and bleeding times were determined before and 3 and 24 hours after CPB. Measurements and Main Results: Ninety minutes after heparin, significant heparin concentrations were present in all vascular surgical patients, but ACT was elevated in only 4 of 17 patients. Protamine titration (Hepcon) correlated with the factor Xa inhibitory assay for heparin (r2 = 0,76). All 17 patients had an abnormal TEG (mean 'R' time = 81 ± 39 minutes) and a marked elevation of aPTT (135 ± 35 sec [normal 22 to 33 seconds]) 90 minutes after heparin. In CPB patients, ACT did not correlate with heparin assays. After protamine neutralization of heparin in CPB patients, ACT returned to baseline despite the presence of heparin in 3 of 29 patients (0.22, 0.18, and 0.33 U/mL). Conclusions: ACT was less sensitive to residual heparin anticoagulation than aPTT, TEG, and whole blood heparin assay. The whole blood heparin assay (Hapcon) provided sensitive and specific data about the presence of residual heparin. Despite the limitation of ACT in detecting heparin, the investigators found that residual heparin was not common in the period after uncomplicated CPB.

AB - Objective: Laboratory and point-of-care coagulation tests are frequently obtained to determine the presence of heparin after surgical procedures. The objective of this study was (1) to compare the sensitivity of the activated coagulation time (ACT), activated partial thromboplastin time (aPTT), protamine titration (Hepcon; HMS Medtronic, Hemotec, Englewood, CO), and thromboelastography (TEG) with heparin anticoagulation and (2) to determine how frequently residual heparin is present in the 24-hour period after heparin neutralization in cardiopulmonary bypass (CPB) patients. Design: A prospective study. Setting: A tertiary care university teaching center that performs more than 15,000 surgical procedures per year. Participants: Vascular surgical (n = 17) and CPB (n = 29). Interventions: In vascular surgical patients, coagulation tests (ACT, protamine titration [Hepcon], and TEG) were obtained before and 90 minutes after heparin (50 to 60 U/kg IV) and compared with heparin concentration determined by factor Xa inhibition assay. In cardiac surgical patients, ACT and heparin concentrations were measured after anesthesia induction, during CPB, after protamine neutralization, and 3 as well as 6 hours after CPB. In addition to heparin concentrations and ACT measures, platelet counts, fibrinogen levels, and bleeding times were determined before and 3 and 24 hours after CPB. Measurements and Main Results: Ninety minutes after heparin, significant heparin concentrations were present in all vascular surgical patients, but ACT was elevated in only 4 of 17 patients. Protamine titration (Hepcon) correlated with the factor Xa inhibitory assay for heparin (r2 = 0,76). All 17 patients had an abnormal TEG (mean 'R' time = 81 ± 39 minutes) and a marked elevation of aPTT (135 ± 35 sec [normal 22 to 33 seconds]) 90 minutes after heparin. In CPB patients, ACT did not correlate with heparin assays. After protamine neutralization of heparin in CPB patients, ACT returned to baseline despite the presence of heparin in 3 of 29 patients (0.22, 0.18, and 0.33 U/mL). Conclusions: ACT was less sensitive to residual heparin anticoagulation than aPTT, TEG, and whole blood heparin assay. The whole blood heparin assay (Hapcon) provided sensitive and specific data about the presence of residual heparin. Despite the limitation of ACT in detecting heparin, the investigators found that residual heparin was not common in the period after uncomplicated CPB.

KW - activated coagulation time

KW - cardiopulmonary bypass

KW - coagulation tests

KW - heparin

UR - http://www.scopus.com/inward/record.url?scp=0031052490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031052490&partnerID=8YFLogxK

U2 - 10.1016/S1053-0770(97)90247-0

DO - 10.1016/S1053-0770(97)90247-0

M3 - Article

C2 - 9058215

AN - SCOPUS:0031052490

VL - 11

SP - 24

EP - 28

JO - Journal of Cardiothoracic and Vascular Anesthesia

JF - Journal of Cardiothoracic and Vascular Anesthesia

SN - 1053-0770

IS - 1

ER -